newsfilter
← Latest News
GlobeNewswire·

Intellia Therapeutics to Present at Jefferies Global Healthcare Conference in London

  • Intellia Therapeutics, Inc. (Nasdaq: NTLA) will present at the Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026.
  • The presentation is scheduled for 8:30 a.m. GMT / 3:30 a.m. ET.
  • A live webcast of the event will be available on the Events page of Intellia's investor website, www.intelliatx.com.
  • A replay of the webcast will remain accessible on the company's website for approximately 90 days.
  • Intellia is a clinical-stage biopharmaceutical company focused on developing curative treatments using CRISPR gene editing technology.
  • Jason Fredette serves as Vice President of Investor Relations & Corporate Communications, while Mike Tattory is Vice President at LifeSci Communications.
Company
Intellia Therapeutics, Inc.
Keywords
Nasdaq:NTLA, Intellia Therapeutics, Inc.